Tucatinib
Back to searchScientific Name: | Tucatinib |
Brand Name: | Tukysa |
Company Owner: | Not Available |
Mechanism Of Action | Mutations in the HER-2 gene are observed in some types of breast carcinoma. Tucatinib inhibits the tyrosine kinase enzyme of the HER-2 gene. |
Description of the Drug: | Tucatinib is a kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer. |
Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB11652